Search

Search results

1934 results found

Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model.

R, Dutta, Khalil R, Mayilsamy K, Green R, Howell M, Bharadwaj S, Mohapatra SS, and Mohapatra S. 2021. “Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model.”. Front Immunol. 2021 Jul 26;12:706133. Doi: 10.3389/Fimmu.2021.706133. PMID: 34381456; PMCID: PMC8350740.

5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages.

Jhun, Bong Sook, Quanri Jin, Young Taek Oh, Sung Soo Kim, Yoon Kong, Yong Ho Cho, Joohun Ha, Hyung Hwan Baik, and Insug Kang. 2004. “5-Aminoimidazole-4-Carboxamide Riboside Suppresses Lipopolysaccharide-Induced TNF-Alpha Production through Inhibition of Phosphatidylinositol 3-Kinase/Akt Activation in RAW 264.7 Murine Macrophages.”. Biochemical and Biophysical Research Communications 318 (2): 372-80.

Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis.

Ha, Chang Hoon, Weiye Wang, Bong Sook Jhun, Chelsea Wong, Angelika Hausser, Klaus Pfizenmaier, Timothy A McKinsey, Eric N Olson, and Zheng-Gen Jin. 2008. “Protein Kinase D-Dependent Phosphorylation and Nuclear Export of Histone Deacetylase 5 Mediates Vascular Endothelial Growth Factor-Induced Gene Expression and Angiogenesis.”. The Journal of Biological Chemistry 283 (21): 14590-9.